EJC Supplements (Nov 2021)

Can the peptide receptor radionuclide therapy [177Lu]Lu-DOTA-TATE provide a net benefit for NET patients?

  • Martyn E. Caplin

Journal volume & issue
Vol. 16
pp. 1 – 4

Abstract

Read online

No abstracts available.

Keywords